Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
Central antinociceptive effects of cannabinoids have been well documented. However, relatively little is known about the peripheral effects of the cannabinoids on inflammation. In the present study, we evaluated the effects of peripherally administered cannabinoids on three indices of inflammation:...
Saved in:
| Published in: | Pain (Amsterdam) Vol. 75; no. 1; p. 111 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.03.1998
|
| Subjects: | |
| ISSN: | 0304-3959, 1872-6623 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Central antinociceptive effects of cannabinoids have been well documented. However, relatively little is known about the peripheral effects of the cannabinoids on inflammation. In the present study, we evaluated the effects of peripherally administered cannabinoids on three indices of inflammation: carrageenan-induced thermal hyperalgesia, carrageenan-induced edema, and capsaicin-induced plasma extravasation. In addition, we determined the effect of cannabinoids on capsaicin-evoked neuropeptide release from isolated rat hindpaw skin. Our results indicate that cannabinoids produce antihyperalgesia via interaction with a peripheral CB1 receptor. Peripheral, but not systemic, administration of 0.01 ng anandamide inhibited the induction of hyperalgesia. Peripheral administration of anandamide also attenuated hyperalgesia after its development via interaction with the CB1 cannabinoid receptor subtype as indicated by its reversal with the CB1 receptor antagonist SR 141716A. Additionally, peripheral, but not systemic, administration of 0.01 ng anandamide inhibited edema. Peripherally administered cannabinoids also interacted with CB1 receptors to inhibit capsaicin-evoked plasma extravasation into the hindpaw. One potential mechanism for the anti-inflammatory actions of the cannabinoids is the inhibition of neurosecretion from the peripheral terminals of nociceptive primary afferent fibers. This hypothesis is supported by the finding that anandamide inhibited capsaicin-evoked release of calcitonin gene-related peptide from isolated hindpaw skin. Collectively, these results indicate that cannabinoids reduce inflammation via interaction with a peripheral CB1 receptor. A potential mechanism for this effect is the inhibition of neurosecretion from capsaicin-sensitive primary afferent fibers. |
|---|---|
| AbstractList | Central antinociceptive effects of cannabinoids have been well documented. However, relatively little is known about the peripheral effects of the cannabinoids on inflammation. In the present study, we evaluated the effects of peripherally administered cannabinoids on three indices of inflammation: carrageenan-induced thermal hyperalgesia, carrageenan-induced edema, and capsaicin-induced plasma extravasation. In addition, we determined the effect of cannabinoids on capsaicin-evoked neuropeptide release from isolated rat hindpaw skin. Our results indicate that cannabinoids produce antihyperalgesia via interaction with a peripheral CB1 receptor. Peripheral, but not systemic, administration of 0.01 ng anandamide inhibited the induction of hyperalgesia. Peripheral administration of anandamide also attenuated hyperalgesia after its development via interaction with the CB1 cannabinoid receptor subtype as indicated by its reversal with the CB1 receptor antagonist SR 141716A. Additionally, peripheral, but not systemic, administration of 0.01 ng anandamide inhibited edema. Peripherally administered cannabinoids also interacted with CB1 receptors to inhibit capsaicin-evoked plasma extravasation into the hindpaw. One potential mechanism for the anti-inflammatory actions of the cannabinoids is the inhibition of neurosecretion from the peripheral terminals of nociceptive primary afferent fibers. This hypothesis is supported by the finding that anandamide inhibited capsaicin-evoked release of calcitonin gene-related peptide from isolated hindpaw skin. Collectively, these results indicate that cannabinoids reduce inflammation via interaction with a peripheral CB1 receptor. A potential mechanism for this effect is the inhibition of neurosecretion from capsaicin-sensitive primary afferent fibers.Central antinociceptive effects of cannabinoids have been well documented. However, relatively little is known about the peripheral effects of the cannabinoids on inflammation. In the present study, we evaluated the effects of peripherally administered cannabinoids on three indices of inflammation: carrageenan-induced thermal hyperalgesia, carrageenan-induced edema, and capsaicin-induced plasma extravasation. In addition, we determined the effect of cannabinoids on capsaicin-evoked neuropeptide release from isolated rat hindpaw skin. Our results indicate that cannabinoids produce antihyperalgesia via interaction with a peripheral CB1 receptor. Peripheral, but not systemic, administration of 0.01 ng anandamide inhibited the induction of hyperalgesia. Peripheral administration of anandamide also attenuated hyperalgesia after its development via interaction with the CB1 cannabinoid receptor subtype as indicated by its reversal with the CB1 receptor antagonist SR 141716A. Additionally, peripheral, but not systemic, administration of 0.01 ng anandamide inhibited edema. Peripherally administered cannabinoids also interacted with CB1 receptors to inhibit capsaicin-evoked plasma extravasation into the hindpaw. One potential mechanism for the anti-inflammatory actions of the cannabinoids is the inhibition of neurosecretion from the peripheral terminals of nociceptive primary afferent fibers. This hypothesis is supported by the finding that anandamide inhibited capsaicin-evoked release of calcitonin gene-related peptide from isolated hindpaw skin. Collectively, these results indicate that cannabinoids reduce inflammation via interaction with a peripheral CB1 receptor. A potential mechanism for this effect is the inhibition of neurosecretion from capsaicin-sensitive primary afferent fibers. Central antinociceptive effects of cannabinoids have been well documented. However, relatively little is known about the peripheral effects of the cannabinoids on inflammation. In the present study, we evaluated the effects of peripherally administered cannabinoids on three indices of inflammation: carrageenan-induced thermal hyperalgesia, carrageenan-induced edema, and capsaicin-induced plasma extravasation. In addition, we determined the effect of cannabinoids on capsaicin-evoked neuropeptide release from isolated rat hindpaw skin. Our results indicate that cannabinoids produce antihyperalgesia via interaction with a peripheral CB1 receptor. Peripheral, but not systemic, administration of 0.01 ng anandamide inhibited the induction of hyperalgesia. Peripheral administration of anandamide also attenuated hyperalgesia after its development via interaction with the CB1 cannabinoid receptor subtype as indicated by its reversal with the CB1 receptor antagonist SR 141716A. Additionally, peripheral, but not systemic, administration of 0.01 ng anandamide inhibited edema. Peripherally administered cannabinoids also interacted with CB1 receptors to inhibit capsaicin-evoked plasma extravasation into the hindpaw. One potential mechanism for the anti-inflammatory actions of the cannabinoids is the inhibition of neurosecretion from the peripheral terminals of nociceptive primary afferent fibers. This hypothesis is supported by the finding that anandamide inhibited capsaicin-evoked release of calcitonin gene-related peptide from isolated hindpaw skin. Collectively, these results indicate that cannabinoids reduce inflammation via interaction with a peripheral CB1 receptor. A potential mechanism for this effect is the inhibition of neurosecretion from capsaicin-sensitive primary afferent fibers. |
| Author | Kilo, Sonja Richardson, Jennelle Durnett Hargreaves, Kenneth M |
| Author_xml | – sequence: 1 givenname: Jennelle Durnett surname: Richardson fullname: Richardson, Jennelle Durnett organization: Department of Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA Department of Restorative Sciences, University of Minnesota, Minneapolis, MN 55455, USA – sequence: 2 givenname: Sonja surname: Kilo fullname: Kilo, Sonja – sequence: 3 givenname: Kenneth M surname: Hargreaves fullname: Hargreaves, Kenneth M |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/9539680$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kEtPwzAQhC0EKm3hJ1TKCcEh4Ecb20eIeEmVOADnaGOvqVHihDgF9d9joOK02tU3M5qdkcPQBSRkweglo6y4eqaCLnOhV_pcywtKORO5OCBTpiTPi4KLQzL9R47JLMZ3mijO9YRM9EroQtEpqUoIAWofOm9jNqDdGsw2ux4HaN4wesgg2MwH10Dbwui7kH2mow9jIszv_uXHTZYEvt_8qLLyhiUjg_3YDfGEHDloIp7u55y83t2-lA_5-un-sbxe50ZIxXPhrMOacbG0KBUqCuAMNU6mppYJ6RRaWlMoBDUcuFM1ULOqNTeSa8YMn5OzP99-6D62GMeq9dFg00DAbhsrqVOMZCqBiz24rVu0VT_4FoZdtf8I_wawsGdQ |
| CitedBy_id | crossref_primary_10_1152_jn_2001_86_1_40 crossref_primary_10_1046_j_1460_9568_2003_02703_x crossref_primary_10_1002_cne_24154 crossref_primary_10_1038_sj_bjp_0704310 crossref_primary_10_1111_j_1521_0391_2014_12135_x crossref_primary_10_1159_000072669 crossref_primary_10_1016_S0165_6147_99_01430_3 crossref_primary_10_1016_j_pain_2006_07_008 crossref_primary_10_4103_ijmr_IJMR_1402_15 crossref_primary_10_1002_neu_20080 crossref_primary_10_1016_j_neuropharm_2007_06_003 crossref_primary_10_1054_plef_2001_0362 crossref_primary_10_1054_plef_2001_0361 crossref_primary_10_1016_S0953_7112_99_90008_X crossref_primary_10_1016_j_ejphar_2006_03_021 crossref_primary_10_1016_S0014_5793_00_01223_0 crossref_primary_10_1038_sj_bjp_0703906 crossref_primary_10_1523_JNEUROSCI_4298_03_2004 crossref_primary_10_1016_S1526_5900_00_90082_8 crossref_primary_10_1074_jbc_M807120200 crossref_primary_10_1016_j_pbb_2012_05_008 crossref_primary_10_1371_journal_pone_0278186 crossref_primary_10_1016_S0301_0082_00_00031_9 crossref_primary_10_1038_bjp_2008_298 crossref_primary_10_1016_j_pain_2005_09_005 crossref_primary_10_1016_j_phrs_2012_02_012 crossref_primary_10_1371_journal_pone_0290871 crossref_primary_10_1016_j_neuroimage_2018_01_067 crossref_primary_10_1124_jpet_102_043893 crossref_primary_10_1213_ANE_0000000000000070 crossref_primary_10_1016_j_cger_2007_12_009 crossref_primary_10_1016_S0306_4522_99_00220_1 crossref_primary_10_1016_S0009_3084_02_00154_8 crossref_primary_10_1016_S1042_3699_20_30149_7 crossref_primary_10_1523_JNEUROSCI_4071_08_2009 crossref_primary_10_1002_ejp_1148 crossref_primary_10_1016_j_neuroscience_2005_08_005 crossref_primary_10_1155_2024_1228194 crossref_primary_10_1016_j_rdc_2008_04_005 crossref_primary_10_1016_j_pbb_2021_173192 crossref_primary_10_1016_S0304_3959_99_00045_7 crossref_primary_10_1016_j_peptides_2005_03_031 crossref_primary_10_1046_j_1460_9568_2003_02957_x crossref_primary_10_3389_fvets_2019_00313 crossref_primary_10_1021_acs_jmedchem_6b00516 crossref_primary_10_1016_S0301_0082_02_00009_6 crossref_primary_10_1371_journal_pone_0006893 crossref_primary_10_1007_BF02854900 crossref_primary_10_1053_j_gastro_2007_02_035 crossref_primary_10_1186_s13075_014_0437_9 crossref_primary_10_7717_peerj_40 crossref_primary_10_1016_j_neuroscience_2009_05_024 crossref_primary_10_1016_S1348_8643_12_00003_1 crossref_primary_10_1016_j_npep_2011_07_011 crossref_primary_10_1016_j_lfs_2005_05_021 crossref_primary_10_1016_S0009_3084_02_00155_X crossref_primary_10_1007_s00482_004_0349_8 crossref_primary_10_1080_00224499_2019_1605328 crossref_primary_10_1016_j_neulet_2011_01_013 crossref_primary_10_1111_bph_15208 crossref_primary_10_1016_j_mcna_2006_10_012 crossref_primary_10_1016_S0304_3959_03_00068_X crossref_primary_10_1186_1744_8069_5_59 crossref_primary_10_1016_S0028_3908_00_00135_0 crossref_primary_10_1016_j_ceca_2009_03_003 crossref_primary_10_1007_s00429_012_0425_2 crossref_primary_10_1016_j_bmc_2007_01_013 crossref_primary_10_1016_S0024_3205_03_00651_9 crossref_primary_10_1111_ejn_70216 crossref_primary_10_1152_jn_01096_2006 crossref_primary_10_1016_j_imbio_2010_03_009 crossref_primary_10_1016_S0028_3908_03_00195_3 crossref_primary_10_1016_j_nbd_2004_11_009 crossref_primary_10_1152_jn_90809_2008 crossref_primary_10_1113_jphysiol_2001_013489 crossref_primary_10_1038_sj_bjp_0704113 crossref_primary_10_1038_sj_bjp_0704110 crossref_primary_10_1111_fcp_12008 crossref_primary_10_1006_bbrc_1999_1105 crossref_primary_10_1016_S0163_7258_02_00258_9 crossref_primary_10_1080_13556210071252 crossref_primary_10_1016_S0024_3205_02_02086_6 crossref_primary_10_1016_S0165_6147_99_01436_4 crossref_primary_10_1016_S0304_3959_01_00336_0 crossref_primary_10_1016_j_bmcl_2012_04_128 crossref_primary_10_1016_j_brainres_2008_03_063 crossref_primary_10_1097_j_pain_0000000000001278 crossref_primary_10_1016_j_jsxm_2021_01_001 crossref_primary_10_1523_JNEUROSCI_3475_14_2014 crossref_primary_10_1523_JNEUROSCI_3322_08_2008 crossref_primary_10_1016_j_neuropharm_2011_05_024 crossref_primary_10_1124_jpet_115_229971 crossref_primary_10_1016_S0889_857X_05_70117_4 crossref_primary_10_1590_0103_8478cr20180595 crossref_primary_10_1016_j_phrs_2010_03_007 crossref_primary_10_1016_S0304_3959_02_00271_3 crossref_primary_10_1038_sj_bjp_0707506 crossref_primary_10_1111_bph_13849 crossref_primary_10_1111_j_1610_0387_2009_07213_x crossref_primary_10_1016_j_neuroscience_2008_04_047 crossref_primary_10_1038_sj_bjp_0704466 crossref_primary_10_1172_JCI200419465 crossref_primary_10_1523_JNEUROSCI_1565_06_2008 crossref_primary_10_1124_jpet_109_163998 crossref_primary_10_1038_sj_bjp_0704223 crossref_primary_10_1016_j_bmcl_2008_10_070 crossref_primary_10_1016_j_ejphar_2006_11_062 crossref_primary_10_1002_ana_10465 crossref_primary_10_1124_mol_110_068940 crossref_primary_10_1208_aapsj080234 crossref_primary_10_1016_S0014_5793_98_01175_2 crossref_primary_10_1016_j_biopha_2021_112279 crossref_primary_10_1523_JNEUROSCI_21_04_01104_2001 crossref_primary_10_1016_j_neuropharm_2011_11_021 crossref_primary_10_1007_s10072_011_0620_6 crossref_primary_10_1021_jm058183t crossref_primary_10_1016_j_lfs_2011_01_017 crossref_primary_10_1007_s00213_011_2224_5 crossref_primary_10_1016_S0024_3205_99_00289_1 crossref_primary_10_1038_sj_bjp_0704904 crossref_primary_10_1139_y2012_130 crossref_primary_10_1016_S0304_3940_02_01221_1 crossref_primary_10_1016_S0306_4522_98_00524_7 crossref_primary_10_1186_1471_2474_11_276 crossref_primary_10_2165_11585260_000000000_00000 crossref_primary_10_1016_S0306_4522_01_00601_7 crossref_primary_10_1016_j_ejphar_2015_02_052 crossref_primary_10_1038_sj_bjp_0706510 crossref_primary_10_3390_jcm11030558 crossref_primary_10_1038_sj_bjp_0706990 crossref_primary_10_1124_pr_58_3_2 crossref_primary_10_1093_bja_aen107 crossref_primary_10_1016_j_drugalcdep_2019_01_021 crossref_primary_10_1097_00001756_200006260_00028 crossref_primary_10_1369_0022155413491269 crossref_primary_10_1006_nbdi_1998_0218 crossref_primary_10_1016_S0306_4522_03_00126_X crossref_primary_10_1021_jm4005626 crossref_primary_10_1097_j_pain_0000000000002268 crossref_primary_10_1016_S0009_3084_02_00145_7 crossref_primary_10_1124_dmd_110_033712 crossref_primary_10_1016_j_ejphar_2008_03_003 crossref_primary_10_1186_1471_2202_6_4 crossref_primary_10_1111_j_1476_5381_2012_02098_x crossref_primary_10_1016_j_pneurobio_2017_10_008 crossref_primary_10_1038_sj_bjp_0705412 crossref_primary_10_1152_jn_00498_2006 crossref_primary_10_1038_sj_bjp_0706984 crossref_primary_10_1046_j_1533_2500_2001_01026_x crossref_primary_10_1124_jpet_104_067587 crossref_primary_10_1016_S0169_409X_03_00101_7 crossref_primary_10_1016_j_bcp_2018_08_022 crossref_primary_10_1093_bja_aen119 crossref_primary_10_1186_1744_8069_10_27 crossref_primary_10_1016_j_ejphar_2004_12_031 crossref_primary_10_1016_j_tvjl_2005_10_003 crossref_primary_10_1002_adhm_201500996 crossref_primary_10_5402_2011_593894 crossref_primary_10_1194_jlr_M800337_JLR200 crossref_primary_10_1177_1049909110369531 crossref_primary_10_1016_j_phrs_2010_02_001 crossref_primary_10_1016_j_npep_2011_03_005 crossref_primary_10_1016_S0028_3908_02_00040_0 crossref_primary_10_1177_1744806920969476 crossref_primary_10_1006_nbdi_1998_0220 crossref_primary_10_1136_bjsm_2004_011718 crossref_primary_10_1016_S0006_8993_98_01321_3 crossref_primary_10_1038_sj_bjp_0706699 crossref_primary_10_1073_pnas_96_10_5802 crossref_primary_10_1016_S0006_8993_98_01368_7 crossref_primary_10_1124_jpet_107_119941 crossref_primary_10_1016_j_brainres_2009_02_061 crossref_primary_10_1186_1129_2377_15_14 crossref_primary_10_1016_j_neulet_2023_137536 crossref_primary_10_1016_j_pain_2005_07_008 crossref_primary_10_1152_jn_1999_81_2_575 crossref_primary_10_1016_j_jpain_2008_12_012 crossref_primary_10_1074_jbc_M101607200 crossref_primary_10_1016_j_ejphar_2008_08_005 crossref_primary_10_1111_evj_13499 crossref_primary_10_1016_j_pain_2013_05_017 crossref_primary_10_1016_j_ejphar_2017_01_030 crossref_primary_10_1007_s11916_017_0619_7 crossref_primary_10_1111_j_1442_2042_2008_02018_x crossref_primary_10_1080_15360288_2025_2457101 crossref_primary_10_1016_S0165_6147_00_01484_X crossref_primary_10_1152_jn_00395_2005 crossref_primary_10_1038_bjp_2008_335 crossref_primary_10_1038_sj_bjp_0707411 crossref_primary_10_1016_j_neuropharm_2005_12_002 crossref_primary_10_1517_13543784_9_7_1553 crossref_primary_10_1038_s41598_022_13284_0 crossref_primary_10_1038_nn1916 crossref_primary_10_1016_j_lfs_2009_06_012 crossref_primary_10_1016_S1042_3699_20_30228_4 crossref_primary_10_1016_S0304_3959_00_00474_7 crossref_primary_10_1016_S0306_4522_03_00333_6 crossref_primary_10_1021_jm020329q crossref_primary_10_1124_jpet_118_252288 crossref_primary_10_1016_j_aat_2013_10_004 crossref_primary_10_1016_j_pain_2010_07_019 crossref_primary_10_1097_FBP_0b013e3282f00c10 crossref_primary_10_1016_j_pain_2004_02_020 crossref_primary_10_1016_j_pain_2007_04_032 crossref_primary_10_1111_j_1440_1681_2010_05346_x crossref_primary_10_1093_bja_87_1_3 crossref_primary_10_1016_S0306_4522_03_00200_8 crossref_primary_10_1038_sj_bjp_0705467 crossref_primary_10_1007_s12017_009_8079_9 crossref_primary_10_2165_00023210_200317030_00004 crossref_primary_10_1124_jpet_103_052381 crossref_primary_10_1016_j_bbadis_2020_165891 crossref_primary_10_1590_S0102_695X2013000500016 crossref_primary_10_1124_mol_62_3_705 crossref_primary_10_1016_S0304_3940_98_00621_1 crossref_primary_10_1016_S0165_6147_00_01482_6 crossref_primary_10_1517_13543780802691951 crossref_primary_10_1016_j_neuropharm_2013_09_022 crossref_primary_10_1111_head_12570 crossref_primary_10_1016_j_cden_2006_09_007 crossref_primary_10_1517_13543784_16_7_951 crossref_primary_10_1155_2016_7917528 crossref_primary_10_1371_journal_pone_0079523 crossref_primary_10_1016_j_pain_2005_12_007 crossref_primary_10_1016_j_pain_2012_07_037 crossref_primary_10_1124_pr_55_1_1 crossref_primary_10_1016_S1526_5900_00_90085_3 crossref_primary_10_1016_j_bbadis_2007_03_002 crossref_primary_10_1136_gut_2007_146621 crossref_primary_10_1016_S0306_4522_02_00449_9 crossref_primary_10_1111_ejn_12431 crossref_primary_10_1016_j_pbb_2013_02_008 crossref_primary_10_1016_j_biopha_2023_115714 crossref_primary_10_1016_S0022_3565_24_35067_0 crossref_primary_10_1213_01_ane_0000194587_94260_1d crossref_primary_10_1016_j_neuropharm_2012_05_032 crossref_primary_10_1046_j_1471_4159_2003_01550_x crossref_primary_10_1002_ddr_20098 crossref_primary_10_1038_35040576 crossref_primary_10_1523_JNEUROSCI_2657_04_2004 crossref_primary_10_1002_cbdv_200790150 crossref_primary_10_1016_j_physbeh_2015_01_038 crossref_primary_10_3390_ijms22179472 crossref_primary_10_1016_S0014_2999_01_01477_7 crossref_primary_10_1113_jphysiol_2001_013290 crossref_primary_10_3389_fphar_2022_881810 crossref_primary_10_1152_physrev_00026_2005 crossref_primary_10_2165_00003495_200161070_00005 crossref_primary_10_1038_srep33307 crossref_primary_10_1002_glia_20084 crossref_primary_10_1038_sj_bjp_0704199 crossref_primary_10_1371_journal_pone_0295432 crossref_primary_10_1152_physrev_00004_2003 crossref_primary_10_1016_j_jdermsci_2005_01_007 crossref_primary_10_1016_S0304_3940_98_00534_5 crossref_primary_10_1016_j_pain_2004_01_022 crossref_primary_10_1016_j_anclin_2007_07_004 crossref_primary_10_1016_j_pain_2004_01_020 crossref_primary_10_1016_S0163_7258_00_00090_5 crossref_primary_10_1177_082585970201800207 crossref_primary_10_4102_safp_v64i1_5493 crossref_primary_10_1016_j_archoralbio_2010_05_006 crossref_primary_10_1016_j_neulet_2018_11_045 crossref_primary_10_1016_j_neuropharm_2007_10_021 crossref_primary_10_1021_jm070317a crossref_primary_10_1016_S0014_2999_01_01309_7 crossref_primary_10_1038_nn_2632 crossref_primary_10_1139_cjpp_2019_0015 crossref_primary_10_1006_mcne_2000_0844 crossref_primary_10_1002_art_23156 crossref_primary_10_1016_j_brainres_2005_10_026 crossref_primary_10_1177_026119290303100313 crossref_primary_10_1016_j_ejphar_2006_08_045 crossref_primary_10_1016_S0014_2999_97_01621_X crossref_primary_10_1111_j_1468_2982_2007_01312_x crossref_primary_10_1016_j_jpain_2024_01_335 crossref_primary_10_7759_cureus_41929 crossref_primary_10_1016_j_pain_2006_04_001 crossref_primary_10_1016_j_pnpbp_2012_01_007 crossref_primary_10_1016_S0304_3959_01_00321_9 crossref_primary_10_1016_S1526_5900_00_90084_1 crossref_primary_10_1038_sj_bjp_0703890 crossref_primary_10_1038_sj_bjp_0707210 crossref_primary_10_1016_j_plipres_2018_05_002 crossref_primary_10_1179_016164107X228642 crossref_primary_10_2217_pmt_2020_0110 crossref_primary_10_1016_j_pain_2005_03_037 crossref_primary_10_1517_13543784_14_6_695 crossref_primary_10_1111_j_1365_2982_2010_01587_x crossref_primary_10_3390_ijms21207693 crossref_primary_10_1016_j_neuropharm_2005_11_002 crossref_primary_10_1111_j_0906_6705_2005_0321b_x crossref_primary_10_1136_acupmed_2016_011113 crossref_primary_10_2147_JPR_S336773 crossref_primary_10_1038_sj_bjp_0705711 crossref_primary_10_1038_sj_bjp_0707326 crossref_primary_10_1136_rapm_2021_102719 crossref_primary_10_1016_j_euroneuro_2011_04_004 crossref_primary_10_1016_S0014_2999_01_01142_6 crossref_primary_10_1016_j_neuroscience_2014_07_041 crossref_primary_10_1111_ejn_12467 crossref_primary_10_1016_S0306_4522_00_00389_4 crossref_primary_10_1016_S0750_7658_02_00592_0 crossref_primary_10_1016_S0005_2760_98_00042_3 crossref_primary_10_1073_pnas_0603861103 crossref_primary_10_1016_j_brainres_2004_03_045 crossref_primary_10_1073_pnas_0401292101 crossref_primary_10_3390_ijms25116268 crossref_primary_10_1038_nrd3673 crossref_primary_10_1016_S0304_3959_02_00401_3 crossref_primary_10_4049_jimmunol_170_10_4953 crossref_primary_10_1073_pnas_96_21_12198 crossref_primary_10_1016_S0750_7658_02_00663_9 crossref_primary_10_1016_S0014_2999_00_00226_0 crossref_primary_10_1016_j_neuroscience_2013_05_003 crossref_primary_10_1016_S0306_4522_02_00420_7 crossref_primary_10_1111_j_1476_5381_2009_00184_x crossref_primary_10_1080_15504263_2019_1668100 crossref_primary_10_1152_jn_1999_82_1_472 crossref_primary_10_1016_j_tips_2008_10_008 crossref_primary_10_1016_S0304_3959_02_00302_0 crossref_primary_10_1016_S0885_3924_01_00252_4 crossref_primary_10_1016_S0014_2999_01_00988_8 crossref_primary_10_1161_01_RES_87_8_670 crossref_primary_10_1007_BF03012696 crossref_primary_10_1111_ejn_12475 crossref_primary_10_1038_nn_3612 crossref_primary_10_3389_fphar_2016_00257 crossref_primary_10_1016_S0163_7258_02_00252_8 crossref_primary_10_1016_j_pbb_2023_173692 crossref_primary_10_1007_s00213_015_3907_0 crossref_primary_10_1016_j_bmcl_2012_02_048 crossref_primary_10_1016_S0304_3959_02_00450_5 crossref_primary_10_1016_S0014_2999_03_01813_2 crossref_primary_10_1016_S0022_3565_24_39213_4 crossref_primary_10_1016_j_neulet_2007_12_053 crossref_primary_10_1111_j_1464_410X_2010_09583_x crossref_primary_10_1016_S0306_4522_02_00870_9 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/S0304-3959(97)00213-3 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1872-6623 |
| ExternalDocumentID | 9539680 |
| Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
| GrantInformation_xml | – fundername: NIDCR NIH HHS grantid: DE9860 |
| GroupedDBID | --- --K .55 .GJ .~1 026 0R~ 123 1B1 1CY 1RT 1~. 1~5 29O 3O- 4.4 4G. 53G 5VS 7-5 71M 9JO AAAAV AAAXR AABNK AACTN AAGIX AAGUQ AAHPQ AAIKJ AAIQE AALRI AAMOA AAQFI AAQKA AAQQT AARTV AASCR AASXQ AAUEB AAXQO AAXUO ABASU ABBQC ABBUW ABCQJ ABDIG ABFNM ABIVO ABJNI ABLJU ABMAC ABOCM ABVCZ ABXVJ ABZAD ABZDS ABZZY ACDDN ACDOF ACEWG ACGFO ACGFS ACIJW ACILI ACIUM ACJTP ACLDA ACNWC ACOAL ACWDW ACWRI ACXJB ACXNI ACXNZ ACZKN ADBBV ADGGA ADHPY ADNKB AEETU AEKER AENEX AERZD AFBFQ AFDTB AFMBP AFSOK AFXBA AGGSO AGWIK AGYEJ AHHHB AHOMT AHQNM AHVBC AHXIK AIJEX AINUH AITUG AJCLO AJIOK AJNWD AJNYG AJRQY AJZMW AKCTQ AKRWK AKULP ALCLG ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AMRAJ AOHHW AOQMC BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIWNM DU5 DUNZO EBS ECM EEVPB EIF EJD EO8 EO9 EP2 EP3 ERAAH EX3 F5P FCALG FDB FEDTE FGOYB FIRID FNPLU G-2 G-Q GNXGY GQDEL HDV HLJTE HMK HMO HMQ HVGLF HZ~ H~9 IHE IKREB IKYAY IPNFZ J1W J5H L-C L7B LX1 M29 M2V M41 MJL MO0 N9A NPM O-L O9- OBH OHT OPUJH OUVQU OVD OVDNE OVIDH OVLEI OVOZU OXXIT OZT P-8 P-9 P2P PC. Q38 R2- RIG RLZ ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SNS SSZ TEORI TSPGW TWZ WUQ X7M XPP YCJ ZGI ZZMQN 7X8 AAYWO ABPXF AIGII AKBMS AKYEP ~HD |
| ID | FETCH-LOGICAL-c3782-3fdfeb1234de78e80aafc0cf7016d137f8ed0b0a630c2a2f8ba0c5b92c72911c2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 411 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00006396-199803000-00012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0304-3959 |
| IngestDate | Sun Nov 09 13:10:36 EST 2025 Thu Apr 03 06:57:49 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3782-3fdfeb1234de78e80aafc0cf7016d137f8ed0b0a630c2a2f8ba0c5b92c72911c2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 9539680 |
| PQID | 79782718 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_79782718 pubmed_primary_9539680 |
| PublicationCentury | 1900 |
| PublicationDate | 1998-March-01 |
| PublicationDateYYYYMMDD | 1998-03-01 |
| PublicationDate_xml | – month: 03 year: 1998 text: 1998-March-01 day: 01 |
| PublicationDecade | 1990 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Pain (Amsterdam) |
| PublicationTitleAlternate | Pain |
| PublicationYear | 1998 |
| SSID | ssj0002229 |
| Score | 2.1356866 |
| Snippet | Central antinociceptive effects of cannabinoids have been well documented. However, relatively little is known about the peripheral effects of the cannabinoids... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 111 |
| SubjectTerms | Animals Anti-Inflammatory Agents - pharmacology Arachidonic Acids - pharmacology Calcitonin Gene-Related Peptide - metabolism Capillary Permeability - drug effects Capsaicin - pharmacology Carrageenan Edema - chemically induced Edema - prevention & control Endocannabinoids Hindlimb - blood supply Hyperalgesia - chemically induced Hyperalgesia - physiopathology Hyperalgesia - prevention & control Male Polyunsaturated Alkamides Rats Rats, Sprague-Dawley Receptors, Cannabinoid Receptors, Drug - drug effects Receptors, Drug - physiology Skin - drug effects Skin - metabolism |
| Title | Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/9539680 https://www.proquest.com/docview/79782718 |
| Volume | 75 |
| WOSCitedRecordID | wos00006396-199803000-00012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF6qFfHiu1ife_Cgh9DNbpLNgiBaLB5sKajQW9jsAwuS1ET7-53Nw57Eg5ccFpIsk8nMNzsz3yB0GWoOTisC5Ab-GwIUwbw0qA7gnfpQw4WuvvQTn0zi2UxMO-im7YVxZZWtTawMtc6VOyMfcAh3KBjS28WH52ZGudxqM0BjDXUZABlX0MVnK65wN6m6ziHAq0UoVv07g-efxSvBr52fYx77HWNWvma0879d7qLtBmPiu1op9lDHZPtoc9xk0Q9QMpRZJiEkzue6xIUjbzX4DQLSwg39KOcSy0xjUD3QlrqzES9h0TFLFHUfBHbHt9iRJFesBO94eO_Dg1yJTF6Uh-h19PAyfPSaQQueYrBfj1ltwWZTFmjDYxMTKa0iynKQlfYZt7HRJCUyYkRRSW2cSqLCVFAF0Nz3Fe2h9SzPzBHCgS9ppFMdAa4JYkLTVEWWcSOYBuBmbB9dtIJLQJFddkJmJv8qk1Z0fdSrZZ8sar6NRIRMRDE5_vPWE7TVtgwS_xR1LfzB5gxtqOXnvCzOK_WA62Q6_gZi5cQZ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cannabinoids+reduce+hyperalgesia+and+inflammation+via+interaction+with+peripheral+CB1+receptors&rft.jtitle=Pain+%28Amsterdam%29&rft.au=Richardson%2C+Jennelle+Durnett&rft.au=Kilo%2C+Sonja&rft.au=Hargreaves%2C+Kenneth+M&rft.date=1998-03-01&rft.issn=0304-3959&rft.eissn=1872-6623&rft.volume=75&rft.issue=1&rft.spage=111&rft_id=info:doi/10.1016%2FS0304-3959%2897%2900213-3&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-3959&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-3959&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-3959&client=summon |